BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15662138)

  • 1. The tumor suppressor p33ING1b enhances taxol-induced apoptosis by p53-dependent pathway in human osteosarcoma U2OS cells.
    Zhu JJ; Li FB; Zhou JM; Liu ZC; Zhu XF; Liao WM
    Cancer Biol Ther; 2005 Jan; 4(1):39-47. PubMed ID: 15662138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells.
    Zhu JJ; Li FB; Zhu XF; Liao WM
    Life Sci; 2006 Feb; 78(13):1469-77. PubMed ID: 16325212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intact ING1-P53 pathway can potentiate the cytotoxic effects of taxol.
    Garkavtsev I; Boucher Y
    Cancer Biol Ther; 2005 Jan; 4(1):48-9. PubMed ID: 15711122
    [No Abstract]   [Full Text] [Related]  

  • 4. [p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide].
    Zhu JJ; Liao WM; Li FB; Zhu XF; Zhou JM; Liu ZC
    Ai Zheng; 2004 Jun; 23(6):640-4. PubMed ID: 15191662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
    Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
    Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
    Kelling J; Sullivan K; Wilson L; Jordan MA
    Cancer Res; 2003 Jun; 63(11):2794-801. PubMed ID: 12782584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle arrest and apoptosis induced by aspidin PB through the p53/p21 and mitochondria-dependent pathways in human osteosarcoma cells.
    Wan D; Jiang C; Hua X; Wang T; Chai Y
    Anticancer Drugs; 2015 Oct; 26(9):931-41. PubMed ID: 26181229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
    Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
    Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [p14ARF enhances cisplatin-induced apoptosis in human osteosarcoma cells in p53-independent pathway].
    Huang X; Yuan X; Chen Z; Liang S
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(35):2875-9. PubMed ID: 26815194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p33ING1b and estrogen receptor (ER) alpha.
    Toyama T; Iwase H
    Breast Cancer; 2004; 11(1):33-7. PubMed ID: 14718790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXA5 overexpression promotes osteosarcoma cell apoptosis through the p53 and p38α MAPK pathway.
    Chen YQ; Yang TQ; Zhou B; Yang MX; Feng HJ; Wang YL
    Gene; 2019 Mar; 689():18-23. PubMed ID: 30521886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
    Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner.
    Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Cancer Biol Ther; 2007 Jul; 6(7):1074-80. PubMed ID: 17611411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
    Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
    Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
    Choi YH; Yoo YH
    Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
    Xie XK; Yang DS; Ye ZM; Tao HM
    Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p14ARF enhances chemosensitivity to cisplatin in human osteosarcoma U2OS cells through p53 apoptotic pathway].
    Yuan X; Huang X; Chen Z; Liang S; Liao W
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(43):3443-6. PubMed ID: 25622680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.